http://campath.legalview.com/msn/ 2012-02-23 http://campath.legalview.com/msn/sanofi-genzyme-agree-on-due-diligence-amidst-merger-talks-update/1279504/ 2012-02-23 http://campath.legalview.com/msn/sanofi-aventis-raises-bid-for-genzyme-brining-deal-closer/1279503/ 2012-02-23 http://campath.legalview.com/msn/pancreas-allograft-biopsies-with-positive-c4d-staining-and-anti-donor/1235942/ 2012-02-23 http://campath.legalview.com/msn/genzyme-rejects-sanofi-offer/1235941/ 2012-02-23 http://campath.legalview.com/msn/genzyme-confirms-receipt-of-unsolicited-proposal/1235940/ 2012-02-23 http://campath.legalview.com/msn/genzyme-rejects-sanofi-aventis-bear-hug/1235939/ 2012-02-23 http://campath.legalview.com/msn/genzyme-rejects-21bn-sanofi-offer/1235938/ 2012-02-23 http://campath.legalview.com/msn/ftse-100-above-5500-ahead-of-basel-meeting-as-rightmove-rises-on-bid-t/1235937/ 2012-02-23 http://campath.legalview.com/msn/investors-genzyme-sale-is-inevitable/1235936/ 2012-02-23 http://campath.legalview.com/msn/genzyme-shoots-down-sanofi-aventiss-buyout-offer/1235935/ 2012-02-23 http://campath.legalview.com/msn/genzyme-snubs-sanofi-aventis-acquisition-offer/1235934/ 2012-02-23 http://campath.legalview.com/msn/farmaceutica-americana-acha-que-vale-mais/1235933/ 2012-02-23 http://campath.legalview.com/msn/billion-dollar-drugs/1235932/ 2012-02-23 http://campath.legalview.com/msn/genzyme-touts-value-of-ms-drug-but-view-may-be-optimistic/1235931/ 2012-02-23 http://campath.legalview.com/msn/genzymes-honey-wont-be-sweet-enough-for-sanofi/1235930/ 2012-02-23 http://campath.legalview.com/msn/genmab-announces-change-in-management/1198013/ 2012-02-23 http://campath.legalview.com/msn/genzyme-ms-drug-gets-fda-fast-track/1198012/ 2012-02-23 http://campath.legalview.com/msn/fda-grants-fast-track-status-to-genzyme-ms-drug/1198011/ 2012-02-23 http://campath.legalview.com/msn/genzyme-ms-drug-granted-fast-track-status/1198010/ 2012-02-23 http://campath.legalview.com/msn/genzyme-not-for-sale-drug-on-fast-track/1198009/ 2012-02-23 http://campath.legalview.com/msn/genzymes-ms-drug-gets-fda-fast-track/1198008/ 2012-02-23 http://campath.legalview.com/msn/fda-grants-fast-track-status-to-genzyme-ms-drug/1198007/ 2012-02-23 http://campath.legalview.com/msn/fast-track-designation-granted-for-alemtuzumab-for-multiple-sclerosis/1198006/ 2012-02-23 http://campath.legalview.com/msn/genzymes-alemtuzumab-gets-fda-fast-track-status-update/1198005/ 2012-02-23 http://campath.legalview.com/msn/today-in-globe-business/1198004/ 2012-02-23 http://campath.legalview.com/msn/genzymes-alemtuzumab-for-treatment-of-multiple-sclerosis-granted-fast/1198003/ 2012-02-23 http://campath.legalview.com/msn/genzyme-drug-on-fda-fast-track/1198002/ 2012-02-23 http://campath.legalview.com/msn/genzymes-ms-therapy-on-the-fast-track-competition-heats-up/1198001/ 2012-02-23 http://campath.legalview.com/msn/genzyme-corporation-financial-and-strategic-analysis/1159959/ 2012-02-23 http://campath.legalview.com/msn/genmab-announces-results-for-the-nine-months-period-of-2009/1132300/ 2012-02-23 http://campath.legalview.com/msn/genzyme-corporation-medical-equipment-deals-and-alliances-profile/1132299/ 2012-02-23 http://campath.legalview.com/msn/genzyme-targets-growth-taligen-takes-26m-icahn-lays-into-biogen/1110336/ 2012-02-23 http://campath.legalview.com/msn/genzyme-acquires-rights-to-bayer-ms-target/1110335/ 2012-02-23 http://campath.legalview.com/msn/you-are-currently-following-mike-havrilla/1110334/ 2012-02-23 http://campath.legalview.com/msn/glaxo-genmab-say-us-extends-review-of-cancer-drug-update2/1110333/ 2012-02-23 http://campath.legalview.com/msn/figuring-out-who-will-benefit-most-from-a-new-therapy-for-multiple/1110332/ 2012-02-23 http://campath.legalview.com/msn/buyinsnet-lsr-ntri-ccmp-ctsh-genz-usna-are-seasonally-ripe-to/1110331/ 2012-02-23 http://campath.legalview.com/msn/an-experimental-drug-is-helping-one-women-stay-ahead-of-ms/1110330/ 2012-02-23 http://campath.legalview.com/msn/mad-money-features/1110329/ 2012-02-23 http://campath.legalview.com/msn/you-are-currently-following-mark-mitchell/1110328/ 2012-02-23 http://campath.legalview.com/msn/genzyme-to-pay-bayer-up-to-28b-for-ms-cancer-drugs/1110327/ 2012-02-23